TP53 and neuroendocrine carcinoma: Large cell NEC generally has more heterogenous genetics with a lower fraction of cases demonstrating co-alteration of TP53 and RB1 compared with small cell NEC; this genetic heterogeneity likely reflects the morphologic variability of this group as well, with a fraction of cases likely representing G3 NET.